| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | RALGAPA1 SOX11 SP2 SRF DAXX SIX4 EZH2 NEDD4 GFI1B PHC3 SALL1 NFE2L1 SAP130 NPAT TBX22 ZNF438 FOXO1 PHF12 KAT6A BEND3 RIOX1 WDR5 IRX3 RUNX2 RUNX1 HDAC7 ZFPM2 SCML4 YEATS2 RESF1 ATF7IP TET1 SORBS3 SP5 SPEN | 7.67e-07 | 1413 | 209 | 35 | GO:1902679 |
| GeneOntologyBiologicalProcess | embryonic organ development | SOX11 MYF5 SP2 SRF SIX4 DSCAML1 HOXB5 DCANP1 MRTFB SALL1 PAX8 KAT6A TRIOBP RUNX2 RUNX1 ZFPM2 PLXNA4 NCOA1 MYO15A PCNT | 1.21e-06 | 561 | 209 | 20 | GO:0048568 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | RALGAPA1 SOX11 SP2 SRF DAXX SIX4 EZH2 NEDD4 GFI1B PHC3 SALL1 NFE2L1 SAP130 NPAT TBX22 ZNF438 FOXO1 PHF12 KAT6A BEND3 RIOX1 WDR5 IRX3 RUNX2 RUNX1 HDAC7 ZFPM2 SCML4 YEATS2 ATF7IP TET1 SORBS3 SP5 SPEN | 1.73e-06 | 1399 | 209 | 34 | GO:0045892 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SOX11 MYF5 ASXL1 UBE4B ASH1L SRF SIX4 DSCAML1 NEDD4 HOXB5 DCANP1 MRTFB SALL1 DMRT3 AJAP1 PAX8 PSG8 KIF26B HCN1 KAT6A TRIOBP LAMB2 IRX3 RUNX2 ZFPM2 ASXL3 ANKRD11 SP5 CTNS MYO15A PCNT | 4.75e-06 | 1269 | 209 | 31 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryo development | SOX11 MYF5 SP2 SPEG MAP3K20 SRF CLASP2 SIX4 DSCAML1 HOXB5 DCANP1 MRTFB SALL1 PAX8 NPAT FN1 KAT6A TRIOBP WDR5 IRX3 RUNX2 RUNX1 ZFPM2 YEATS2 TET1 PLXNA4 ANKRD11 NCOA1 MACF1 MYO15A CCDC24 PCNT | 2.15e-05 | 1437 | 209 | 32 | GO:0009790 |
| GeneOntologyBiologicalProcess | nephron epithelium development | 4.91e-05 | 128 | 209 | 8 | GO:0072009 | |
| GeneOntologyBiologicalProcess | ureteric bud elongation | 5.53e-05 | 8 | 209 | 3 | GO:0060677 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | RALGAPA1 SOX11 SP2 DAXX EZH2 NEDD4 GFI1B SALL1 NFE2L1 SAP130 TBX22 FOXO1 PHF12 BEND3 WDR5 IRX3 RUNX1 HDAC7 ZFPM2 YEATS2 ATF7IP TET1 SORBS3 SP5 SPEN | 6.83e-05 | 1053 | 209 | 25 | GO:0000122 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX11 MYF5 ASXL1 ASH1L SRF DAXX ZNF395 SIX4 MAP3K1 GFI1B HOXB5 MRTFB SALL1 PAX8 NFE2L1 CX3CL1 NPAT FOXO1 IRX3 RUNX2 RUNX1 ZFPM2 USF3 LMO7 ASXL3 TET1 NCOA1 NCOA7 PRKD1 TP53BP1 | 7.09e-05 | 1390 | 209 | 30 | GO:0045944 |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 8.02e-05 | 44 | 209 | 5 | GO:0006346 | |
| GeneOntologyBiologicalProcess | regulation of nucleus organization | 1.02e-04 | 2 | 209 | 2 | GO:1903353 | |
| GeneOntologyBiologicalProcess | kidney morphogenesis | 1.38e-04 | 111 | 209 | 7 | GO:0060993 | |
| GeneOntologyBiologicalProcess | skeletal system development | SOX11 MYF5 ASXL1 DYM ASH1L SRF SIX4 PTGER4 DSCAML1 HOXB5 DCANP1 WDR5 RUNX2 RUNX1 ARSL ANKRD11 SP5 | 1.86e-04 | 615 | 209 | 17 | GO:0001501 |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.89e-04 | 242 | 209 | 10 | GO:0098727 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | RABEP2 MAP3K20 CUL9 DAZ1 CLASP2 PTGER4 CNTROB MAP3K1 NFE2L1 PIP4K2A CX3CL1 GNL3 SLAIN2 DAZ4 SYNE1 MYO19 ARFGEF1 TRIOBP KLHL22 WDR47 MAPRE1 RESF1 ATF7IP SORBS3 PRKD1 MPHOSPH9 RIMS2 CDC23 | 2.22e-04 | 1342 | 209 | 28 | GO:0033043 |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 2.35e-04 | 55 | 209 | 5 | GO:0140718 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | SRF CLASP2 SIX4 SALL1 DIP2B FN1 KIF26B LAMB2 PLXNA4 MACF1 RIMS2 | 2.49e-04 | 299 | 209 | 11 | GO:0060560 |
| GeneOntologyBiologicalProcess | kidney epithelium development | 2.53e-04 | 162 | 209 | 8 | GO:0072073 | |
| GeneOntologyBiologicalProcess | nephron tubule morphogenesis | 2.57e-04 | 87 | 209 | 6 | GO:0072078 | |
| GeneOntologyBiologicalProcess | nephron epithelium morphogenesis | 2.91e-04 | 89 | 209 | 6 | GO:0072088 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | MYF5 SRF CLASP2 AJAP1 CX3CL1 COL17A1 FN1 TRIOBP LAMB2 SNED1 RADIL SORBS3 MACF1 | 2.97e-04 | 410 | 209 | 13 | GO:0031589 |
| GeneOntologyBiologicalProcess | ureteric bud invasion | 3.05e-04 | 3 | 209 | 2 | GO:0072092 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis | 3.05e-04 | 3 | 209 | 2 | GO:0072309 | |
| GeneOntologyBiologicalProcess | vagus nerve development | 3.05e-04 | 3 | 209 | 2 | GO:0021564 | |
| GeneOntologyBiologicalProcess | nephron morphogenesis | 3.28e-04 | 91 | 209 | 6 | GO:0072028 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.33e-04 | 33 | 209 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SOX11 MYF5 MAP3K20 SRF CLASP2 SIX4 DSCAML1 HOXB5 DCANP1 SALL1 PAX8 FN1 TRIOBP IRX3 RUNX2 NCOA1 MACF1 MYO15A | 3.62e-04 | 713 | 209 | 18 | GO:0048598 |
| GeneOntologyBiologicalProcess | renal tubule morphogenesis | 3.69e-04 | 93 | 209 | 6 | GO:0061333 | |
| GeneOntologyBiologicalProcess | nephron development | 4.09e-04 | 174 | 209 | 8 | GO:0072006 | |
| GeneOntologyBiologicalProcess | metanephros development | 4.14e-04 | 95 | 209 | 6 | GO:0001656 | |
| GeneOntologyBiologicalProcess | metanephric renal vesicle morphogenesis | 4.27e-04 | 15 | 209 | 3 | GO:0072283 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-1 alpha production | 4.27e-04 | 15 | 209 | 3 | GO:0032650 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | RABEP2 MARK1 ADGRB2 SRF CLASP2 SIX4 PTGER4 CNTROB MAP3K1 LRFN5 METTL18 PIP4K2A CX3CL1 SLAIN2 SYNE1 ARFGEF1 TRIOBP IRX3 MAPRE1 RESF1 ATF7IP SORBS3 MACF1 PRKD1 MPHOSPH9 | 4.40e-04 | 1189 | 209 | 25 | GO:0044087 |
| GeneOntologyBiologicalProcess | axon extension | 4.60e-04 | 135 | 209 | 7 | GO:0048675 | |
| GeneOntologyCellularComponent | chromatin | SOX11 MYF5 SP2 TSHZ2 HDX SRF DAXX SIX4 EZH2 FOXD4L5 NEDD4 HOXB5 FOXD4L4 SALL1 DMRT3 PAX8 NFE2L1 SAP130 TBX22 FOXO1 EP400 PHF12 ICE2 KAT6A BEND3 WDR5 IRX3 RUNX2 RUNX1 ZFPM2 YEATS2 TET1 ANKRD11 SP5 NCOA1 TMPO STAG3 | 2.57e-07 | 1480 | 211 | 37 | GO:0000785 |
| GeneOntologyCellularComponent | microtubule plus-end | 1.71e-04 | 28 | 211 | 4 | GO:0035371 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.22e-04 | 85 | 211 | 6 | GO:0000118 | |
| GeneOntologyCellularComponent | microtubule end | 5.69e-04 | 38 | 211 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | PR-DUB complex | 6.00e-04 | 4 | 211 | 2 | GO:0035517 | |
| HumanPheno | Lower limb asymmetry | 2.56e-05 | 46 | 67 | 6 | HP:0100559 | |
| HumanPheno | Limitation of joint mobility | GPHN ASXL1 SLC29A3 DYM UBE4B LEMD3 SPEG MAP3K20 EZH2 SCN9A HERC1 FN1 HCN1 SYNE1 LAMB2 SPEN PCNT | 2.78e-05 | 432 | 67 | 17 | HP:0001376 |
| HumanPheno | Upper eyelid edema | 4.23e-05 | 6 | 67 | 3 | HP:0012724 | |
| HumanPheno | Hypoplastic iliac wing | 4.41e-05 | 31 | 67 | 5 | HP:0002866 | |
| Domain | CH | 1.32e-04 | 70 | 209 | 6 | PF00307 | |
| Domain | - | 1.43e-04 | 71 | 209 | 6 | 1.10.418.10 | |
| Domain | CH | 1.67e-04 | 73 | 209 | 6 | PS50021 | |
| Domain | CH-domain | 1.94e-04 | 75 | 209 | 6 | IPR001715 | |
| Domain | Rap_GAP_dom | 2.13e-04 | 11 | 209 | 3 | IPR000331 | |
| Domain | RAPGAP | 2.13e-04 | 11 | 209 | 3 | PS50085 | |
| Domain | HARE-HTH | 3.71e-04 | 3 | 209 | 2 | PF05066 | |
| Domain | ASXH | 3.71e-04 | 3 | 209 | 2 | PF13919 | |
| Domain | Runt | 3.71e-04 | 3 | 209 | 2 | PF00853 | |
| Domain | PHD_3 | 3.71e-04 | 3 | 209 | 2 | PF13922 | |
| Domain | RUNT | 3.71e-04 | 3 | 209 | 2 | PS51062 | |
| Domain | ASX-like_PHD | 3.71e-04 | 3 | 209 | 2 | IPR026905 | |
| Domain | ASXH | 3.71e-04 | 3 | 209 | 2 | IPR028020 | |
| Domain | TF_Runt-rel_RUNX | 3.71e-04 | 3 | 209 | 2 | IPR016554 | |
| Domain | RunxI | 3.71e-04 | 3 | 209 | 2 | PF08504 | |
| Domain | Runt_dom | 3.71e-04 | 3 | 209 | 2 | IPR013524 | |
| Domain | RunxI_C_dom | 3.71e-04 | 3 | 209 | 2 | IPR013711 | |
| Domain | ASX/ASX-like | 3.71e-04 | 3 | 209 | 2 | IPR024811 | |
| Domain | Runx_central_dom | 3.71e-04 | 3 | 209 | 2 | IPR027384 | |
| Domain | HB1/Asxl_HTH | 3.71e-04 | 3 | 209 | 2 | IPR007759 | |
| Domain | - | 3.71e-04 | 3 | 209 | 2 | 4.10.770.10 | |
| Domain | AML1_Runt | 3.71e-04 | 3 | 209 | 2 | IPR000040 | |
| Domain | CH | 8.01e-04 | 65 | 209 | 5 | SM00033 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN RALGAPA1 GAPVD1 MAP3K20 CLASP2 IRS1 DENND2B PPM1H NEDD4 ZCCHC14 PLEKHG1 NAV2 FOXO1 SLAIN2 DIP2B KIF26B RANBP3 RALGAPB INPP5F NCKAP5L HDAC7 RADIL MAP7D1 MTMR4 RESF1 LMO7 TET1 ANKRD11 NCOA7 MACF1 FAM53B MPHOSPH9 USP54 PCM1 | 5.91e-18 | 861 | 213 | 34 | 36931259 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX11 MYF5 SP2 TSHZ2 ASH1L HDX SRF ZNF395 SIX4 EZH2 ZC3H3 GFI1B HOXB5 FOXD4L4 SALL1 DMRT3 PAX8 NFE2L1 TBX22 FOXO1 IRX3 RUNX2 RUNX1 ZFPM2 HIVEP3 YEATS2 USF3 SP5 NCOA1 | 4.23e-13 | 908 | 213 | 29 | 19274049 |
| Pubmed | ASXL1 UBE4B SPEG CUL9 NEDD4 GRAMD1B ZCCHC14 PLEKHG1 GSE1 EP400 SYNE1 FRMPD1 RALGAPB BEND3 WDR47 YEATS2 MAP7D1 MACF1 SPEN PCNT | 1.12e-12 | 407 | 213 | 20 | 12693553 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 GAPVD1 UBE4B DAXX EZH2 PHC3 GSE1 PAPOLA OSBPL11 DIP2B EP400 PHF12 RALGAPB RFFL RUNX1 HDAC7 YEATS2 PRICKLE3 LMO7 SORBS3 TMPO SPEN PCM1 TP53BP1 CDC23 | 1.56e-11 | 774 | 213 | 25 | 15302935 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CUL9 DAXX UBN2 MRTFB SALL1 GSE1 PIP4K2A FOXO1 EP400 DTNA PPM1D NCKAP5L YEATS2 RESF1 LMO7 ATF7IP MACF1 SPEN PCM1 TP53BP1 CDC23 PCNT | 1.71e-11 | 588 | 213 | 22 | 38580884 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SP2 SRF SIX4 EZH2 PHC3 SALL1 PIP4K2A EP400 NCKAP5L ZFPM2 YEATS2 RESF1 ATF7IP NCOA1 TMPO USP54 MYO15A | 5.11e-10 | 398 | 213 | 17 | 35016035 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 DYM UBE4B TSHZ2 ATXN7L1 ASH1L SRF L2HGDH CLASP2 UBN2 DENND2B PPM1H MRTFB ANKIB1 SAP130 GNL3 DIP2B DTNA KAT6A FRMPD1 RALGAPB ZDHHC14 TRIOBP HIVEP3 YEATS2 INTS6 USF3 ANKRD11 MACF1 PRKD1 PCM1 PCNT | 6.86e-10 | 1489 | 213 | 32 | 28611215 |
| Pubmed | ATXN7L1 ZNF490 GRAMD1B PLEKHG1 MRTFB SYNE1 RALGAPB GRID1 YEATS2 MACF1 | 8.63e-10 | 103 | 213 | 10 | 10574462 | |
| Pubmed | GAPVD1 PHC3 MRTFB SALL1 GSE1 NPAT PHF12 BEND3 INPP5F YEATS2 MAP7D1 RESF1 ATF7IP TET1 PCM1 CDC23 PCNT | 1.07e-09 | 418 | 213 | 17 | 34709266 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UBE4B SPEG ADGRB2 CUL9 CLASP2 IRS1 ZNF395 CNTROB ZCCHC14 PLEKHG1 EHBP1L1 NAV2 HERC1 EP400 PHF12 KAT6A LAMB2 GRID1 HDAC7 HIVEP3 RADIL GAREM2 SORBS3 ANKRD11 ANKRD34A SPEN PCNT | 1.13e-09 | 1105 | 213 | 27 | 35748872 |
| Pubmed | GPHN EPRS1 GAPVD1 UBN2 MRTFB OSBPL11 SAP130 SLAIN2 EP400 RANBP3 BEND3 YEATS2 LMO7 TET1 TMPO SPEN PCM1 TP53BP1 CDC23 | 1.58e-09 | 549 | 213 | 19 | 38280479 | |
| Pubmed | RALGAPA1 GAPVD1 MARK1 MAP3K20 CLASP2 CNTROB PPM1H PLEKHG1 RALGAPB INPP5F NCKAP5L HDAC7 RADIL LMO7 MPHOSPH9 USP54 PCM1 | 2.84e-09 | 446 | 213 | 17 | 24255178 | |
| Pubmed | SP2 ASXL1 ATXN7L1 CUL9 SIX4 UBN2 PHC3 SALL1 GSE1 PAX8 HERC1 SAP130 GNL3 NPAT EP400 DTNA PHF12 BEND3 WDR5 ZFPM2 YEATS2 MAP7D1 RESF1 ATF7IP NCOA1 USP54 SPEN PCM1 TP53BP1 | 1.66e-08 | 1429 | 213 | 29 | 35140242 | |
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | SOX11 SPEG UBN2 TGM5 GRAMD1B HOXB5 SALL1 GSE1 ICE2 IRX3 ZFPM2 TMPO RIMS2 | 9.79e-08 | 318 | 213 | 13 | 16919269 |
| Pubmed | IL16 ATXN7L1 ASH1L CUL9 ZC3H3 GSE1 PIP4K2A SAP130 GNL3 SLAIN2 EP400 PHF12 KAT6A BEND3 SIPA1 NCKAP5L YEATS2 INTS6 MAP7D1 RESF1 MACF1 USP54 PCM1 CDC23 | 1.11e-07 | 1116 | 213 | 24 | 31753913 | |
| Pubmed | ASXL1 DSCAML1 ZCCHC14 MRTFB NAV2 SYNE1 RALGAPB TRIOBP LMO7 MACF1 PCNT | 1.64e-07 | 225 | 213 | 11 | 12168954 | |
| Pubmed | LEMD3 ASH1L DENND2B NEDD4 MRTFB PAPOLA HERC1 SAP130 FN1 ZNF329 LAMB2 ARHGAP9 MTMR4 ATF7IP MACF1 ZNF83 CCDC181 | 1.69e-07 | 591 | 213 | 17 | 15231748 | |
| Pubmed | LEMD3 HDX L2HGDH EZH2 CDAN1 SALL1 SAP130 EP400 MUC16 YEATS2 MAP7D1 RESF1 SPEN TP53BP1 | 1.85e-07 | 396 | 213 | 14 | 26687479 | |
| Pubmed | SP2 CUL9 PHC3 OSBPL11 SAP130 EP400 INTS7 TUT1 RUNX1 MACF1 SPEN CDC23 | 2.00e-07 | 282 | 213 | 12 | 23667531 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | UBE4B EZH2 MRTFB GSE1 PAPOLA SAP130 EP400 PPM1D RANBP3 ARFGEF1 SBNO1 SPEN TP53BP1 | 2.18e-07 | 341 | 213 | 13 | 32971831 |
| Pubmed | 2.27e-07 | 3 | 213 | 3 | 32187044 | ||
| Pubmed | 2.79e-07 | 10 | 213 | 4 | 23001180 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SPATA31E1 INPP5D MAP3K1 NEDD4 PHC3 MRTFB SALL1 NFE2L1 SAP130 EP400 RANBP3 USF3 SPEN PCNT | 4.99e-07 | 430 | 213 | 14 | 35044719 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | RABEP2 GAPVD1 SPEG L2HGDH CLASP2 TGM5 SCN9A NAV2 HERC1 FN1 MAP7D1 LMO7 ANKRD11 TMPO CDC23 | 5.04e-07 | 497 | 213 | 15 | 36774506 |
| Pubmed | GPHN RABEP2 ADGRB2 CLASP2 UBN2 TMEM132B PPM1H NEDD4 DIP2B HCN1 SYNE1 TRIOBP SIPA1 WDR47 MAP7D1 ATF7IP MACF1 PRKD1 PCM1 TP53BP1 PCNT | 5.79e-07 | 963 | 213 | 21 | 28671696 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 1.10e-06 | 125 | 213 | 8 | 32891193 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPRS1 SP2 LEMD3 ZNF395 SIX4 EZH2 UBN2 PHC3 SAP130 GNL3 EP400 INTS7 PHF12 BEND3 WDR5 RUNX1 YEATS2 INTS6 MAP7D1 LMO7 ANKRD11 TMPO SPEN CDC23 | 1.55e-06 | 1294 | 213 | 24 | 30804502 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.82e-06 | 231 | 213 | 10 | 16452087 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SIX4 UBN2 SALL1 GSE1 EP400 PHF12 WDR5 RESF1 ASXL3 TET1 NCOA1 SPEN | 2.01e-06 | 351 | 213 | 12 | 38297188 |
| Pubmed | EVPL DAXX KIAA1549L NAV2 WIPF1 KIF26B SYNE1 LAMB2 NCKAP5L USF3 ATF7IP MACF1 MPHOSPH9 ZNF83 | 2.10e-06 | 486 | 213 | 14 | 20936779 | |
| Pubmed | RABEP2 RALGAPA1 LEMD3 CLASP2 SIX4 C2CD4C CNTROB PPM1H GSE1 HERC1 DTNA PPM1D RALGAPB TRIOBP NCKAP5L CNNM1 MTMR4 SORBS3 TMPO MPHOSPH9 PCNT | 2.24e-06 | 1049 | 213 | 21 | 27880917 | |
| Pubmed | MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. | 2.24e-06 | 5 | 213 | 3 | 11965546 | |
| Pubmed | 2.24e-06 | 5 | 213 | 3 | 20484411 | ||
| Pubmed | Sex-specific chromatin remodelling safeguards transcription in germ cells. | 2.35e-06 | 16 | 213 | 4 | 34880491 | |
| Pubmed | RABEP2 EPRS1 EVPL EHBP1L1 RANBP3 TRIOBP SIPA1 LMO7 TMPO MACF1 TP53BP1 PCNT | 2.60e-06 | 360 | 213 | 12 | 33111431 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 3.30e-06 | 102 | 213 | 7 | 15778465 | |
| Pubmed | GPHN PLEKHG1 ICE2 TRIOBP BEND3 NCKAP5L LMO7 NCOA7 MPHOSPH9 PCM1 | 3.81e-06 | 251 | 213 | 10 | 29778605 | |
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 4.47e-06 | 6 | 213 | 3 | 26077710 | |
| Pubmed | EPRS1 UBE4B ASH1L CUL9 DSCAML1 MTUS2 FN1 HCN1 SYNE1 ZNF329 TRIOBP RUNX1 WDR47 HEATR6 SBNO1 LMO7 MACF1 USP54 ZNF83 REPS2 CCDC24 PCM1 PCNT | 4.66e-06 | 1285 | 213 | 23 | 35914814 | |
| Pubmed | EPRS1 INPP5D UBN2 GSE1 SAP130 SLAIN2 WIPF1 EP400 PHF12 BEND3 RUNX2 RUNX1 YEATS2 MAP7D1 RESF1 NCOA1 TMPO SPEN PCM1 TP53BP1 CDC23 | 4.87e-06 | 1103 | 213 | 21 | 34189442 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN EPRS1 GAPVD1 PHC3 MRTFB GSE1 PAPOLA OSBPL11 GNL3 EP400 RANBP3 YEATS2 ATF7IP TMPO NCOA7 MACF1 PCM1 TP53BP1 PCNT | 5.56e-06 | 934 | 213 | 19 | 33916271 |
| Pubmed | RALGAPA1 GAPVD1 NACAD ANKIB1 NAV2 SLAIN2 EP400 PHF12 TRIOBP INPP5F LMO7 TET1 FAM53B RIMS2 | 5.56e-06 | 529 | 213 | 14 | 14621295 | |
| Pubmed | LEMD3 MAP3K20 DAXX CLASP2 SIX4 EZH2 UBN2 PHC3 MRTFB METTL18 GNL3 SLAIN2 EP400 INTS7 PHF12 SYNE1 RALGAPB TRIOBP LAMB2 CEP164 INTS6 MAP7D1 ANKRD11 MACF1 SPEN | 5.85e-06 | 1497 | 213 | 25 | 31527615 | |
| Pubmed | 6.07e-06 | 157 | 213 | 8 | 30186101 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GPHN ASXL1 GAPVD1 CUL9 SIX4 SALL1 GSE1 SAP130 FOXO1 KIF27 EP400 FRMPD1 BEND3 WDR47 MAP7D1 CHSY3 SPEN TP53BP1 | 6.42e-06 | 857 | 213 | 18 | 25609649 |
| Pubmed | GAPVD1 LEMD3 CLASP2 C2CD4C SLAIN2 FN1 EP400 ARFGEF1 MUC16 BEND3 PODXL2 MAPRE1 ATF7IP TMPO MPHOSPH9 SPEN PCM1 | 6.90e-06 | 777 | 213 | 17 | 35844135 | |
| Pubmed | Synaptic, transcriptional and chromatin genes disrupted in autism. | 7.79e-06 | 7 | 213 | 3 | 25363760 | |
| Pubmed | Physical and functional link of the leukemia-associated factors AML1 and PML. | 7.79e-06 | 7 | 213 | 3 | 15331439 | |
| Pubmed | SOX11 SLC29A3 ATXN7L1 CUL9 C2CD4C PPM1H PLEKHG1 PIP4K2A NAV2 MTUS2 AOAH VSIG10 HDAC7 RADIL FAM53B PRKD1 MYO15A | 1.26e-05 | 814 | 213 | 17 | 23251661 | |
| Pubmed | EPRS1 GAPVD1 MARK1 ASH1L CLASP2 UBN2 PHC3 PAPOLA NFE2L1 OSBPL11 HERC1 NPAT FN1 FRMPD1 MAPRE1 RESF1 TET1 MACF1 TP53BP1 PCNT | 1.30e-05 | 1084 | 213 | 20 | 11544199 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 GAPVD1 EVPL IRS1 TMEM132B DSCAML1 GSE1 FN1 KIF26B HCN1 MYO19 ROR1 ARHGAP9 THBS4 PLXNA4 TMPO | 1.40e-05 | 736 | 213 | 16 | 29676528 |
| Pubmed | 1.48e-05 | 128 | 213 | 7 | 30995482 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MAP3K20 CLASP2 F5 GSE1 MAPRE1 MAP7D1 LMO7 ASXL3 TMPO MACF1 SPEN | 1.58e-05 | 361 | 213 | 11 | 26167880 |
| Pubmed | 1.64e-05 | 130 | 213 | 7 | 12421765 | ||
| Pubmed | 1.64e-05 | 87 | 213 | 6 | 12465718 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.93e-05 | 184 | 213 | 8 | 32908313 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SP2 HDX DAXX UBN2 SALL1 SLAIN2 EP400 ICE2 YEATS2 RESF1 SBNO1 TMPO | 2.14e-05 | 444 | 213 | 12 | 34795231 |
| Pubmed | ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. | 2.63e-05 | 10 | 213 | 3 | 18854161 | |
| Pubmed | Control of developmentally primed erythroid genes by combinatorial co-repressor actions. | 3.31e-05 | 30 | 213 | 4 | 26593974 | |
| Pubmed | SP2 SRF SIX4 FOXD4L5 ZCCHC14 HOXB5 FOXD4L4 NFE2L1 FOXO1 TUT1 IRX3 PRICKLE3 LMO7 NCOA1 MACF1 | 3.56e-05 | 709 | 213 | 15 | 22988430 | |
| Pubmed | Congenital diaphragmatic hernia candidate genes derived from embryonic transcriptomes. | 3.60e-05 | 11 | 213 | 3 | 22315423 | |
| Pubmed | Y chromosome damage underlies testicular abnormalities in ATR-X syndrome. | 3.60e-05 | 11 | 213 | 3 | 38616920 | |
| Pubmed | 3.60e-05 | 11 | 213 | 3 | 17300925 | ||
| Pubmed | Gradual centriole maturation associates with the mitotic surveillance pathway in mouse development. | 3.60e-05 | 11 | 213 | 3 | 33410253 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 9233771 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 29358618 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 22065775 | ||
| Pubmed | Kendrin/pericentrin-B, a centrosome protein with homology to pericentrin that complexes with PCM-1. | 3.73e-05 | 2 | 213 | 2 | 11171385 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 17997710 | ||
| Pubmed | MACF1 promotes preosteoblast migration by mediating focal adhesion turnover through EB1. | 3.73e-05 | 2 | 213 | 2 | 32139394 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 21455215 | ||
| Pubmed | Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. | 3.73e-05 | 2 | 213 | 2 | 16059634 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 30809307 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 23321257 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 32408395 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 33159702 | ||
| Pubmed | The inositol phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4. | 3.73e-05 | 2 | 213 | 2 | 19125695 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 17533052 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 19029091 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 27634876 | ||
| Pubmed | Identification and expression of a novel 3'-exon of mouse Runx1/Pebp2alphaB/Cbfa2/AML1 gene. | 3.73e-05 | 2 | 213 | 2 | 10903914 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 35692075 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 32180230 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 17290219 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 34902807 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 36946317 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 23936109 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 21289264 | ||
| Pubmed | Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells. | 3.73e-05 | 2 | 213 | 2 | 35551452 | |
| Pubmed | FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. | 3.73e-05 | 2 | 213 | 2 | 21505104 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 25596267 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 22467876 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 31347330 | ||
| Pubmed | 4.29e-05 | 151 | 213 | 7 | 17043677 | ||
| Pubmed | 4.29e-05 | 103 | 213 | 6 | 10819331 | ||
| Pubmed | 4.29e-05 | 103 | 213 | 6 | 21706016 | ||
| Pubmed | MYF5 SP2 ASH1L SRF SIX4 ZCCHC14 GFI1B SALL1 NFE2L1 ZNF438 FOXO1 ZDHHC14 RUNX2 HIVEP3 PRICKLE3 NCOA1 | 4.30e-05 | 808 | 213 | 16 | 20412781 | |
| Pubmed | 4.47e-05 | 152 | 213 | 7 | 38360978 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ADGRB2 CNTROB KIAA1549L ANKIB1 MTUS2 FN1 PHF12 TRIOBP LAMB2 SIPA1 ZFPM2 SORBS3 TMPO | 4.69e-05 | 560 | 213 | 13 | 21653829 |
| Pubmed | 4.78e-05 | 12 | 213 | 3 | 25037921 | ||
| Interaction | YWHAH interactions | RALGAPA1 GAPVD1 MARK1 SPEG MAP3K20 CLASP2 IRS1 ZNF395 DENND2B PPM1H NEDD4 ZCCHC14 PLEKHG1 NAV2 HERC1 FOXO1 SLAIN2 DIP2B FN1 KIF26B RANBP3 RALGAPB INPP5F SIPA1 NCKAP5L HDAC7 FRMD4A RADIL MAP7D1 MTMR4 RESF1 PRICKLE3 LMO7 TET1 ANKRD11 NCOA1 NCOA7 MACF1 FAM53B PRKD1 MPHOSPH9 USP54 RIMS2 PCM1 PCNT | 1.22e-15 | 1102 | 208 | 45 | int:YWHAH |
| Interaction | YWHAG interactions | GPHN RALGAPA1 GAPVD1 MARK1 SPEG MAP3K20 CLASP2 IRS1 ZNF395 EZH2 DENND2B PPM1H MAP3K1 NEDD4 PLEKHG1 NAV2 FOXO1 SLAIN2 FN1 KIF26B RANBP3 RALGAPB INPP5F SIPA1 NCKAP5L HDAC7 FRMD4A RADIL MAP7D1 MTMR4 PRICKLE3 LMO7 TET1 ANKRD11 ANKRD34A MACF1 FAM53B PRKD1 MPHOSPH9 USP54 PCM1 | 3.13e-11 | 1248 | 208 | 41 | int:YWHAG |
| Interaction | YWHAZ interactions | RALGAPA1 ASXL1 GAPVD1 MARK1 SPEG MAP3K20 CLASP2 IRS1 ZNF395 EZH2 DENND2B PPM1H MAP3K1 NEDD4 GRAMD1B NAV2 FOXO1 FN1 KIF26B KAT6A RALGAPB WDR5 INPP5F SIPA1 NCKAP5L HDAC7 MAPRE1 RADIL MAP7D1 MTMR4 PRICKLE3 LMO7 ASXL3 ANKRD34A MACF1 FAM53B PRKD1 MPHOSPH9 USP54 PCM1 TP53BP1 PCNT | 4.59e-11 | 1319 | 208 | 42 | int:YWHAZ |
| Interaction | YWHAB interactions | RALGAPA1 GAPVD1 MARK1 SPEG MAP3K20 CLASP2 IRS1 ZNF395 EZH2 DENND2B PPM1H NEDD4 NAV2 SAP130 FOXO1 SLAIN2 FN1 KIF26B PPM1D KAT6A RALGAPB INPP5F SIPA1 NCKAP5L HDAC7 RADIL MAP7D1 MTMR4 PRICKLE3 LMO7 ANKRD34A MACF1 FAM53B MPHOSPH9 USP54 PCM1 | 7.29e-11 | 1014 | 208 | 36 | int:YWHAB |
| Interaction | YWHAE interactions | RALGAPA1 GAPVD1 MARK1 HDX MAP3K20 CLASP2 IRS1 ZNF395 EZH2 DENND2B PPM1H MAP3K1 NEDD4 PAPOLA NAV2 SAP130 FOXO1 FN1 KIF26B RALGAPB INPP5F NCKAP5L HDAC7 KLHL22 FRMD4A RADIL MAP7D1 MTMR4 PRICKLE3 LMO7 TET1 ANKRD34A TMPO MACF1 FAM53B PRKD1 MPHOSPH9 USP54 RIMS2 PCM1 | 1.45e-10 | 1256 | 208 | 40 | int:YWHAE |
| Interaction | YWHAQ interactions | RALGAPA1 MARK1 SPEG MAP3K20 CLASP2 IRS1 ZNF395 EZH2 DENND2B PPM1H MAP3K1 NEDD4 NAV2 FOXO1 FN1 KIF26B TUT1 INPP5F SIPA1 NCKAP5L HDAC7 MAP7D1 MTMR4 LMO7 TET1 NCOA1 TMPO MACF1 FAM53B PRKD1 MPHOSPH9 USP54 PCM1 | 4.68e-08 | 1118 | 208 | 33 | int:YWHAQ |
| Interaction | HDAC1 interactions | RABEP2 GAPVD1 DAXX ZNF395 EZH2 GFI1B MRTFB SALL1 GSE1 PAPOLA SAP130 NPAT FN1 EP400 PHF12 ARFGEF1 BEND3 WDR5 INPP5F RUNX2 RUNX1 HDAC7 ZFPM2 YEATS2 MAP7D1 LMO7 TET1 SPEN PCM1 CDC23 PCNT | 4.06e-07 | 1108 | 208 | 31 | int:HDAC1 |
| Interaction | PHF21A interactions | GAPVD1 MRTFB SALL1 GSE1 NPAT PHF12 BEND3 INPP5F NCKAP5L YEATS2 MAP7D1 RESF1 TET1 PCM1 PCNT | 2.98e-06 | 343 | 208 | 15 | int:PHF21A |
| Interaction | SFN interactions | RALGAPA1 GAPVD1 MARK1 MAP3K20 CLASP2 IRS1 DENND2B NAV2 SAP130 FOXO1 KIF26B RANBP3 INPP5F NCKAP5L HDAC7 MAP7D1 MTMR4 LMO7 MACF1 FAM53B MPHOSPH9 USP54 | 3.06e-06 | 692 | 208 | 22 | int:SFN |
| Interaction | RCOR1 interactions | EZH2 GFI1B MRTFB SALL1 GSE1 NPAT PHF12 BEND3 LAMB2 NCKAP5L YEATS2 MAP7D1 RESF1 TET1 SPEN PCM1 TP53BP1 CDC23 | 4.00e-06 | 494 | 208 | 18 | int:RCOR1 |
| Interaction | MAPRE3 interactions | KLHDC7B CLASP2 FOXD4L4 NAV2 SLAIN2 DIP2B NCKAP5L MAPRE1 MAP7D1 LMO7 MACF1 PCNT | 5.08e-06 | 230 | 208 | 12 | int:MAPRE3 |
| Interaction | RBBP7 interactions | ASH1L DAXX EZH2 UBN2 CDAN1 SALL1 GSE1 SAP130 GNL3 NPAT EP400 PHF12 BEND3 WDR5 ZFPM2 TET1 SPEN PCNT | 5.72e-06 | 507 | 208 | 18 | int:RBBP7 |
| Interaction | SYNE3 interactions | LEMD3 CNTROB GRAMD1B ZCCHC14 PLEKHG1 GSE1 ETAA1 NCKAP5L CEP164 YEATS2 LMO7 MACF1 MPHOSPH9 USP54 CDC23 PCNT | 1.60e-05 | 444 | 208 | 16 | int:SYNE3 |
| Interaction | CEP63 interactions | RALGAPA1 DAXX EZH2 GSE1 SYNE1 NCKAP5L MACF1 MPHOSPH9 PCM1 PCNT | 1.75e-05 | 179 | 208 | 10 | int:CEP63 |
| Interaction | GOLGA1 interactions | GAPVD1 PLEKHG1 OSBPL11 SLAIN2 MAPRE1 NCOA7 MACF1 MPHOSPH9 PCM1 PCNT | 2.12e-05 | 183 | 208 | 10 | int:GOLGA1 |
| Interaction | DSCR9 interactions | 2.25e-05 | 147 | 208 | 9 | int:DSCR9 | |
| Interaction | HNF4A interactions | EZH2 UBN2 GSE1 SAP130 FOXO1 EP400 PHF12 WDR5 YEATS2 ATF7IP NCOA1 SPEN | 3.04e-05 | 275 | 208 | 12 | int:HNF4A |
| Interaction | ANAPC2 interactions | CUL9 CNTROB OSBPL11 WDR5 NCKAP5L MPHOSPH9 USP54 STAG3 TP53BP1 CDC23 PCNT | 3.33e-05 | 234 | 208 | 11 | int:ANAPC2 |
| Interaction | PML interactions | SP2 HDX SRF DAXX EZH2 UBN2 SAP130 FOXO1 SLAIN2 EP400 INTS7 ICE2 KAT6A WDR5 RUNX2 RUNX1 HDAC7 YEATS2 INTS6 SBNO1 LMO7 ATF7IP TMPO TP53BP1 | 3.66e-05 | 933 | 208 | 24 | int:PML |
| Interaction | ODF2 interactions | EPRS1 MAP3K1 PLEKHG1 FOXO1 NCKAP5L CEP164 LMO7 MPHOSPH9 PCM1 | 3.98e-05 | 158 | 208 | 9 | int:ODF2 |
| Interaction | KDM1A interactions | GAPVD1 IL16 EZH2 GFI1B PHC3 MRTFB GSE1 METTL18 NPAT EP400 PPM1D PHF12 BEND3 WDR5 INPP5F YEATS2 MAP7D1 RESF1 ATF7IP TET1 PCM1 TP53BP1 CDC23 PCNT | 4.19e-05 | 941 | 208 | 24 | int:KDM1A |
| Interaction | MTA2 interactions | GPHN RABEP2 EZH2 EHBP1L1 SALL1 GSE1 SAP130 PHF12 BEND3 WDR5 RUNX1 ZFPM2 SPEN TP53BP1 PCNT | 4.90e-05 | 435 | 208 | 15 | int:MTA2 |
| Interaction | SGF29 interactions | 5.32e-05 | 164 | 208 | 9 | int:SGF29 | |
| Interaction | SOX2 interactions | EPRS1 SP2 MARK1 CUL9 EVPL SIX4 UBN2 TGM5 PHC3 SALL1 GSE1 OSBPL11 NAV2 SAP130 GNL3 SLAIN2 FN1 EP400 INTS7 TRIOBP WDR5 TUT1 RUNX2 RUNX1 KLHL22 FRMD4A TMPO MACF1 SPEN CDC23 PCNT | 6.15e-05 | 1422 | 208 | 31 | int:SOX2 |
| Interaction | FHL2 interactions | SP2 IL16 SRF EZH2 PHC3 MRTFB SAP130 FOXO1 EP400 ARHGAP9 RUNX2 RUNX1 YEATS2 SPEN | 6.73e-05 | 396 | 208 | 14 | int:FHL2 |
| Interaction | GOLGA6L9 interactions | ASXL1 IL16 DAXX ZNF490 HOXB5 ZNF438 ZNF329 ARHGAP9 HDAC7 ANKRD11 | 8.63e-05 | 216 | 208 | 10 | int:GOLGA6L9 |
| Interaction | RBBP4 interactions | ASXL1 ASH1L EZH2 UBN2 SALL1 GSE1 SAP130 GNL3 NPAT FN1 PHF12 BEND3 WDR5 RUNX1 ZFPM2 ASXL3 SPEN | 9.94e-05 | 573 | 208 | 17 | int:RBBP4 |
| Interaction | SRF interactions | 9.97e-05 | 139 | 208 | 8 | int:SRF | |
| Interaction | POU5F1 interactions | LEMD3 L2HGDH EZH2 UBN2 NEDD4 CDAN1 SALL1 SAP130 EP400 MUC16 WDR5 YEATS2 MAP7D1 RESF1 TET1 TMPO TP53BP1 | 1.25e-04 | 584 | 208 | 17 | int:POU5F1 |
| Interaction | CEP135 interactions | CNTROB PLEKHG1 GSE1 NCKAP5L CEP164 MAPRE1 LMO7 MPHOSPH9 USP54 PCM1 PCNT | 1.28e-04 | 272 | 208 | 11 | int:CEP135 |
| Interaction | FBXO22 interactions | RABEP2 GAPVD1 SPEG L2HGDH CLASP2 TGM5 SCN9A NAV2 HERC1 FN1 MAP7D1 LMO7 ANKRD11 TMPO TP53BP1 CDC23 | 1.62e-04 | 540 | 208 | 16 | int:FBXO22 |
| Interaction | HNF1B interactions | 1.64e-04 | 190 | 208 | 9 | int:HNF1B | |
| Interaction | CSNK1A1 interactions | GAPVD1 IRS1 FAM170A PIP4K2A HERC1 KAT6A WDR5 KLHL22 MTMR4 LMO7 TMPO PRKD1 PCM1 | 1.74e-04 | 381 | 208 | 13 | int:CSNK1A1 |
| GeneFamily | PDZ domain containing | 9.86e-04 | 152 | 135 | 6 | 1220 | |
| GeneFamily | LEM domain containing | 1.13e-03 | 7 | 135 | 2 | 1087 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.50e-03 | 8 | 135 | 2 | 939 | |
| GeneFamily | Phosphoinositide phosphatases | 1.72e-03 | 32 | 135 | 3 | 1079 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 1.93e-03 | 9 | 135 | 2 | 755 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 GAPVD1 IL16 INPP5D ASH1L DAXX PTGER4 PHC3 PAPOLA PIP4K2A HERC1 NPAT FOXO1 SLAIN2 WIPF1 EP400 SYNE1 AOAH KAT6A RALGAPB ARHGAP9 RUNX2 SIPA1 SCML4 HIVEP3 MAPRE1 MAP7D1 RESF1 SBNO1 ATF7IP ANKRD11 NCOA1 MACF1 FAM53B SPEN PCM1 | 3.77e-09 | 1492 | 212 | 36 | M40023 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | TSHZ2 ATXN7L1 ASH1L F5 MAP3K1 HERC1 EP400 KAT6A FRMPD1 PCDHB3 USF3 MACF1 | 4.98e-08 | 189 | 212 | 12 | M3112 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SOX11 TSHZ2 MARK1 SPEG UBN2 TMEM132B DSCAML1 FOXD4L5 AJAP1 KIAA1549L GSE1 LRFN5 SCN9A ANKIB1 HERC1 MTUS2 DIP2B ARFGEF1 GRID1 IRX3 ZFPM2 HIVEP3 ASXL3 PLXNA4 NCOA7 CHSY3 RIMS2 | 3.33e-07 | 1106 | 212 | 27 | M39071 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | SOX11 TSHZ2 MARK1 SPEG UBN2 TMEM132B AJAP1 GSE1 ANKIB1 HERC1 MTUS2 ZFPM2 HIVEP3 ASXL3 PLXNA4 RIMS2 | 1.38e-06 | 465 | 212 | 16 | M39066 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | RALGAPA1 ASXL1 UBE4B HERC1 YEATS2 CNNM1 SBNO1 ATF7IP MACF1 PCM1 | 2.24e-06 | 180 | 212 | 10 | M8239 |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | GAPVD1 UBE4B MAP3K1 PIP4K2A ETAA1 OSBPL11 ZDHHC14 SIPA1 ATF7IP NCOA1 | 2.35e-06 | 181 | 212 | 10 | M8662 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | GPHN ASXL1 UBE4B TSHZ2 ATXN7L1 CUL9 L2HGDH DENND2B FN1 SYNE1 KAT6A TRIOBP INTS6 HEATR6 RESF1 ATF7IP PRKD1 | 4.11e-06 | 567 | 212 | 17 | M16909 |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | EZH2 PTGER4 MRTFB KIAA1549L KIF26B FRMD4A MANSC1 ATF7IP MACF1 PRKD1 | 5.01e-06 | 197 | 212 | 10 | M8983 |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | ASXL1 SLC29A3 UBE4B MAP3K1 PIP4K2A FOXO1 HCN1 INTS6 MTMR4 TET1 | 5.48e-06 | 199 | 212 | 10 | M6987 |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 6.41e-06 | 86 | 212 | 7 | M39248 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 GAPVD1 CLASP2 IRS1 DENND2B NEDD4 GSE1 PIP4K2A NPAT ROR1 KAT6A ARFGEF1 INPP5F RUNX1 NCOA1 MACF1 MPHOSPH9 SPEN TP53BP1 PCNT | 2.31e-05 | 856 | 212 | 20 | M4500 |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | 3.06e-05 | 194 | 212 | 9 | M8019 | |
| Coexpression | UDAYAKUMAR_MED1_TARGETS_DN | TNFSF9 EFCAB14 ZNF395 NFE2L1 HERC1 PPM1D INTS6 MAP7D1 REPS2 PCNT | 3.21e-05 | 244 | 212 | 10 | M9945 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | MAP3K20 IRS1 UBN2 PTGER4 DENND2B MAP3K1 PHC3 MRTFB PAPOLA PAX8 HERC1 FOXO1 SLAIN2 DTNA RFFL SNED1 MANSC1 ATF7IP USP54 | 3.36e-05 | 807 | 212 | 19 | M16651 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ASXL1 GAPVD1 IRS1 ZCCHC14 AJAP1 GSE1 METTL18 NPAT FOXO1 KAT6A SPEN | 3.60e-05 | 300 | 212 | 11 | M8702 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | ASXL1 UBE4B ATXN7L1 GRAMD1B PAX8 NFE2L1 DIP2B WIPF1 KIF26B RUNX1 FRMD4A ANKRD11 RIMS2 | 3.85e-05 | 417 | 212 | 13 | M39224 |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_DN | 3.88e-05 | 200 | 212 | 9 | M8471 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 4.97e-05 | 257 | 212 | 10 | M13867 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | IL16 INPP5D DAXX PTGER4 GSE1 PIP4K2A HERC1 FOXO1 WIPF1 SYNE1 AOAH KAT6A ARHGAP9 SIPA1 SCML4 RESF1 SBNO1 ATF7IP MACF1 PCM1 | 5.50e-05 | 911 | 212 | 20 | M40038 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 6.27e-05 | 84 | 212 | 6 | M13008 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | SOX11 TSHZ2 MARK1 CLASP2 C2CD4C TMEM132B AJAP1 KIAA1549L SCN9A MTUS2 WDR47 HIVEP3 ASXL3 PLXNA4 CHSY3 | 8.92e-05 | 584 | 212 | 15 | M39068 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | EPRS1 MARK1 SPEG ASH1L CLASP2 ZNF395 TMEM132B ZCCHC14 GSE1 NFE2L1 NAV2 MTUS2 FOXO1 SLAIN2 ROR1 INPP5F MAPRE1 USF3 SBNO1 PCM1 | 9.19e-05 | 946 | 212 | 20 | M39169 |
| Coexpression | GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP | 9.38e-05 | 175 | 212 | 8 | M6872 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | GAPVD1 SRF CLASP2 IRS1 DMRT3 AJAP1 NAV2 ZNF438 KIF26B PCDHGA2 KAT6A FRMPD1 GRID1 ZFPM2 RADIL MTMR4 ATF7IP TET1 PLXNA4 | 9.51e-05 | 873 | 212 | 19 | M16009 |
| Coexpression | GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN | 1.10e-04 | 179 | 212 | 8 | M6324 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.30e-04 | 137 | 212 | 7 | M39241 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 1.42e-04 | 139 | 212 | 7 | M8948 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING | 1.42e-04 | 237 | 212 | 9 | M7068 | |
| Coexpression | GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP | 1.48e-04 | 187 | 212 | 8 | M3287 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 1.60e-04 | 189 | 212 | 8 | M8275 | |
| Coexpression | EIF4E_DN | 1.65e-04 | 100 | 212 | 6 | M2790 | |
| Coexpression | GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 1.91e-04 | 194 | 212 | 8 | M8017 | |
| Coexpression | GSE28408_LY6G_POS_VS_NEG_DC_UP | 2.12e-04 | 197 | 212 | 8 | M9547 | |
| Coexpression | GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP | 2.19e-04 | 198 | 212 | 8 | M5138 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_DN | 2.27e-04 | 199 | 212 | 8 | M5732 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 2.35e-04 | 200 | 212 | 8 | M9439 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN | 2.35e-04 | 200 | 212 | 8 | M9451 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 2.35e-04 | 200 | 212 | 8 | M5991 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP | 2.35e-04 | 200 | 212 | 8 | M8042 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP | 2.35e-04 | 200 | 212 | 8 | M3404 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP | 2.35e-04 | 200 | 212 | 8 | M8469 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 2.35e-04 | 200 | 212 | 8 | M9041 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN | 2.35e-04 | 200 | 212 | 8 | M6896 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 2.35e-04 | 200 | 212 | 8 | M6993 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 2.46e-04 | 152 | 212 | 7 | M2938 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | GAPVD1 LEMD3 MAP3K20 SRF CLASP2 CD320 EZH2 CDAN1 PAPOLA ICE2 MYO19 BEND3 WDR5 INPP5F VSIG10 MTMR4 MANSC1 SBNO1 SP5 TMPO | 2.58e-04 | 1023 | 212 | 20 | M17122 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL | 2.79e-04 | 71 | 212 | 5 | M45677 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | SOX11 IL16 MAP3K20 PPM1H PLEKHG1 EHBP1L1 SALL1 PAX8 LRFN5 PIP4K2A WIPF1 KIF26B DTNA PCDHB3 ARHGAP9 IRX3 MTMR4 ASXL3 NCOA7 CHSY3 RIMS2 CDC23 | 2.61e-05 | 836 | 208 | 22 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | TSHZ2 MAP3K20 ADGRB2 CLASP2 IRS1 EFCAB14 ZCCHC14 EHBP1L1 LRFN5 PIP4K2A ETAA1 KIF26B HCN1 ROR1 ZFPM2 MAP7D1 THBS4 MTMR4 ASXL3 PLXNA4 TMPO CHSY3 | 2.65e-05 | 837 | 208 | 22 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | SOX11 ASH1L ANKIB1 ICE2 ZNF329 RFFL IRX3 MAP7D1 METTL25B USF3 MACF1 MPHOSPH9 | 3.19e-05 | 291 | 208 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | SOX11 MAP3K20 IRS1 SIX4 SALL1 PAPOLA PIP4K2A COL17A1 WIPF1 KIF26B ROR1 FRMPD1 PCDHB3 RUNX2 RUNX1 YEATS2 LMO7 ATF7IP ASXL3 TMPO CHSY3 RIMS2 | 3.35e-05 | 850 | 208 | 22 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | TSHZ2 ADGRB2 PPM1H TGM5 PLEKHG1 SALL1 PAX8 LRFN5 PIP4K2A WIPF1 KIF26B ROR1 PCDHB3 IRX3 SNED1 THBS4 MTMR4 HEATR6 ASXL3 RIMS2 STAG3 TP53BP1 | 3.65e-05 | 855 | 208 | 22 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | TSHZ2 MARK1 SRF IRS1 ZNF395 DENND2B NAV2 KIF27 FN1 KIF26B MUC16 IRX3 RUNX1 ZFPM2 YEATS2 RESF1 ASXL3 PLXNA4 SP5 PRKD1 REPS2 | 3.94e-05 | 797 | 208 | 21 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | GPHN RALGAPA1 SOX11 ASH1L MRTFB ANKIB1 SLAIN2 PPM1D ICE2 ZNF329 RFFL IRX3 CEP164 MAP7D1 METTL25B USF3 HEATR6 TET1 MACF1 MPHOSPH9 | 8.79e-05 | 780 | 208 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | IL16 TSHZ2 GSE1 FN1 KIF26B DTNA ROR1 RUNX1 HIVEP3 MACF1 PRKD1 | 3.13e-09 | 197 | 213 | 11 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RALGAPA1 ASH1L PHC3 HERC1 SYNE1 ARFGEF1 SCML4 ATF7IP ANKRD11 MACF1 PCM1 | 3.48e-09 | 199 | 213 | 11 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | TMEM132B MRTFB KIAA1549L LRFN5 MTUS2 HCN1 SYNE1 FRMD4A CHSY3 RIMS2 | 3.89e-08 | 196 | 213 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 MAP3K20 DENND2B LRFN5 NAV2 FN1 SYNE1 ZFPM2 SNED1 CHSY3 | 4.08e-08 | 197 | 213 | 10 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 MAP3K20 DENND2B LRFN5 NAV2 FN1 SYNE1 ZFPM2 SNED1 CHSY3 | 4.08e-08 | 197 | 213 | 10 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | TSHZ2 MAP3K20 DENND2B LRFN5 NAV2 FN1 SYNE1 ZFPM2 SNED1 CHSY3 | 4.08e-08 | 197 | 213 | 10 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | TMEM132B MRTFB KIAA1549L LRFN5 MTUS2 HCN1 SYNE1 FRMD4A CHSY3 RIMS2 | 4.28e-08 | 198 | 213 | 10 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | TMEM132B MRTFB KIAA1549L LRFN5 MTUS2 HCN1 SYNE1 FRMD4A CHSY3 RIMS2 | 4.28e-08 | 198 | 213 | 10 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | MRTFB KIAA1549L LRFN5 HERC1 MTUS2 HCN1 SYNE1 FRMD4A CHSY3 RIMS2 | 4.70e-08 | 200 | 213 | 10 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-07 | 186 | 213 | 9 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.09e-07 | 187 | 213 | 9 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | RALGAPA1 ASH1L HERC1 ARFGEF1 ATF7IP ANKRD11 MACF1 SPEN TP53BP1 | 3.23e-07 | 188 | 213 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-07 | 188 | 213 | 9 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.38e-07 | 189 | 213 | 9 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-07 | 190 | 213 | 9 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.03e-07 | 193 | 213 | 9 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.21e-07 | 194 | 213 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-07 | 195 | 213 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-07 | 195 | 213 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-07 | 198 | 213 | 9 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.99e-07 | 198 | 213 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | TMEM132B MRTFB KIAA1549L LRFN5 MTUS2 HCN1 SYNE1 FRMD4A RIMS2 | 4.99e-07 | 198 | 213 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-07 | 199 | 213 | 9 | fbdde57dd88656621801e65ee2818251588f3874 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-07 | 200 | 213 | 9 | 20ffb3436d08042f77800513e6ddb3bbc38ae6fe | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-07 | 200 | 213 | 9 | 8474e5d031d25bfb8461d39fa2053da01a6304fc | |
| ToppCell | RV-17._Lymphocyte|RV / Chamber and Cluster_Paper | 7.60e-07 | 153 | 213 | 8 | e1ea621184014415870e00d511386b8cc3e0833b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-06 | 164 | 213 | 8 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.75e-06 | 171 | 213 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 2.09e-06 | 175 | 213 | 8 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | COPD-Lymphoid-ILC_A|COPD / Disease state, Lineage and Cell class | 2.18e-06 | 176 | 213 | 8 | 484452cb38fe4604f0910a068361ed461b5b0c21 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-06 | 181 | 213 | 8 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-06 | 181 | 213 | 8 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.79e-06 | 182 | 213 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-06 | 183 | 213 | 8 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 3.15e-06 | 185 | 213 | 8 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-06 | 185 | 213 | 8 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-06 | 187 | 213 | 8 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 3.41e-06 | 187 | 213 | 8 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 213 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.55e-06 | 188 | 213 | 8 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-06 | 188 | 213 | 8 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.69e-06 | 189 | 213 | 8 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 190 | 213 | 8 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 190 | 213 | 8 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 190 | 213 | 8 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 3.84e-06 | 190 | 213 | 8 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 3.99e-06 | 191 | 213 | 8 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.15e-06 | 192 | 213 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 4.15e-06 | 192 | 213 | 8 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-06 | 192 | 213 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 4.20e-06 | 136 | 213 | 7 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.31e-06 | 193 | 213 | 8 | 544de0988510cc57744710d7cafe07aa27a0b99d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-06 | 193 | 213 | 8 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-06 | 193 | 213 | 8 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-06 | 194 | 213 | 8 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.48e-06 | 194 | 213 | 8 | 5031f324628ff12a33e84cc52157be4786e0961d | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 5.01e-06 | 197 | 213 | 8 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.01e-06 | 197 | 213 | 8 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.01e-06 | 197 | 213 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.20e-06 | 198 | 213 | 8 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.20e-06 | 198 | 213 | 8 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD8-positive,_alpha-beta_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.20e-06 | 198 | 213 | 8 | 41ead3d3733b79e3e45648d5ce1909e617c35ed7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-06 | 198 | 213 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-06 | 198 | 213 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.40e-06 | 199 | 213 | 8 | 0d6463e368fd611a17327322413fad145f3c7f32 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.40e-06 | 199 | 213 | 8 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.40e-06 | 199 | 213 | 8 | b947ecaf912d97869f6df32736b8c2b2dd695d66 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-06 | 200 | 213 | 8 | be9a43acc2f926b9433ab3f018b911b03896a924 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-06 | 200 | 213 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-06 | 200 | 213 | 8 | dfdfad881c114e1bc9a64b411e1b00fb37cc859b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.60e-06 | 200 | 213 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.60e-06 | 200 | 213 | 8 | f7a9d8b99de19e9842422bada348d940e0863645 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.02e-06 | 147 | 213 | 7 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.74e-06 | 152 | 213 | 7 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 156 | 213 | 7 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 156 | 213 | 7 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 158 | 213 | 7 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 158 | 213 | 7 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.32e-05 | 162 | 213 | 7 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-05 | 169 | 213 | 7 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-05 | 169 | 213 | 7 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.95e-05 | 172 | 213 | 7 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-05 | 174 | 213 | 7 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-05 | 176 | 213 | 7 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-05 | 176 | 213 | 7 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 176 | 213 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 177 | 213 | 7 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.56e-05 | 121 | 213 | 6 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.61e-05 | 180 | 213 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-05 | 181 | 213 | 7 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-05 | 183 | 213 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 183 | 213 | 7 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.90e-05 | 183 | 213 | 7 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-05 | 183 | 213 | 7 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 184 | 213 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 184 | 213 | 7 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 184 | 213 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 184 | 213 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.08e-05 | 125 | 213 | 6 | 6cd741dd1c7ee6b16437cca7c15c99b5c95603fc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 185 | 213 | 7 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | ASXL1 LEMD3 IRS1 GRAMD1B MRTFB OSBPL11 NAV2 NPAT PPM1D KAT6A RUNX1 WDR47 | 1.31e-07 | 180 | 212 | 12 | 4541_DN |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; HL60; HT_HG-U133A | RALGAPA1 SRF PIP4K2A FOXO1 PODXL2 TUT1 RUNX1 PIGZ CNNM1 PRICKLE3 NCOA1 CTNS | 2.80e-07 | 193 | 212 | 12 | 2459_DN |
| Drug | Anabasine [494-52-0]; Down 200; 24.6uM; MCF7; HT_HG-U133A | TNFSF9 DENND2B PAPOLA DTNA RUNX1 CEP164 KLHL22 ORAI3 CTNS RIMS2 STAG3 PCM1 | 3.89e-07 | 199 | 212 | 12 | 6074_DN |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | GPHN PPM1H GRAMD1B MRTFB NAV2 ROR1 ARFGEF1 YEATS2 ATF7IP ANKRD11 NCOA1 | 6.32e-07 | 171 | 212 | 11 | 7535_DN |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | IL16 INPP5D MAP3K20 GRAMD1B PAX8 FN1 DTNA MYO19 SIPA1 MANSC1 CTNS | 2.30e-06 | 195 | 212 | 11 | 2956_DN |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; PC3; HT_HG-U133A | SPEG L2HGDH HOXB5 KIAA1549L PAPOLA WIPF1 EP400 RUNX1 KLHL22 METTL25B FAM53B | 2.54e-06 | 197 | 212 | 11 | 6727_DN |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | ASH1L ZC3H3 ETAA1 DTNA RANBP3 KAT6A TUT1 KLHL22 SORBS3 CTNS RIMS2 | 2.80e-06 | 199 | 212 | 11 | 7330_DN |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | ATXN7L1 ADGRB2 PAPOLA KAT6A TUT1 MANSC1 SBNO1 TMPO MPHOSPH9 SPEN | 1.47e-05 | 194 | 212 | 10 | 4309_DN |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | MAP3K20 IL20RA PAPOLA TRIOBP RUNX1 HDAC7 FRMD4A LMO7 STAG3 PCM1 | 1.54e-05 | 195 | 212 | 10 | 5744_DN |
| Drug | boron trichloride | 1.56e-05 | 6 | 212 | 3 | CID000025135 | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A | TNFSF9 DENND2B HOXB5 WIPF1 DTNA ROR1 SORBS3 FAM53B CTNS STAG3 | 1.61e-05 | 196 | 212 | 10 | 6615_DN |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | SPEG HOXB5 FN1 PODXL2 TUT1 HDAC7 KLHL22 METTL25B LMO7 SORBS3 | 1.61e-05 | 196 | 212 | 10 | 5765_DN |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; PC3; HG-U133A | EPRS1 LEMD3 EFCAB14 GSE1 PAPOLA EP400 INTS7 ARFGEF1 RESF1 TMPO | 1.61e-05 | 196 | 212 | 10 | 1892_DN |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 1.61e-05 | 196 | 212 | 10 | 2221_UP | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; PC3; HT_HG-U133A | RALGAPA1 MAP3K20 L2HGDH NEDD4 PHC3 HOXB5 SYNE1 CEP164 CNNM1 TMPO | 1.61e-05 | 196 | 212 | 10 | 4469_DN |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A | ASH1L L2HGDH EHBP1L1 C1orf54 INTS7 RANBP3 ZDHHC14 ARFGEF1 TRIOBP SORBS3 | 1.61e-05 | 196 | 212 | 10 | 2406_DN |
| Drug | fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A | RALGAPA1 UBE4B LEMD3 TNFSF9 TGM5 PAX8 C1orf54 RUNX1 CTNS PCM1 | 1.68e-05 | 197 | 212 | 10 | 282_UP |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; HL60; HG-U133A | ASXL1 CLASP2 EFCAB14 FN1 EP400 INTS7 THBS4 MACF1 MPHOSPH9 CTNS | 1.76e-05 | 198 | 212 | 10 | 1595_DN |
| Drug | Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | EHBP1L1 ETAA1 INTS7 DTNA RANBP3 ZDHHC14 KLHL22 SORBS3 NCOA1 PCM1 | 1.76e-05 | 198 | 212 | 10 | 3313_DN |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; PC3; HG-U133A | SRF L2HGDH DENND2B NPAP1 DTNA RUNX2 VSIG10 SIPA1 ORAI3 FAM53B | 1.76e-05 | 198 | 212 | 10 | 1900_UP |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A | MYF5 IL16 ATXN7L1 SPEG MAP3K1 EHBP1L1 KAT6A RUNX1 HDAC7 SORBS3 | 1.83e-05 | 199 | 212 | 10 | 1527_UP |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A | RALGAPA1 MAP3K20 PHC3 PAPOLA RANBP3 TRIOBP RUNX1 HDAC7 HIVEP3 STAG3 | 1.92e-05 | 200 | 212 | 10 | 4372_DN |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.40e-05 | 177 | 212 | 9 | 4652_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.47e-05 | 182 | 212 | 9 | 3630_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.47e-05 | 182 | 212 | 9 | 5802_DN | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A | 7.62e-05 | 190 | 212 | 9 | 5080_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.93e-05 | 191 | 212 | 9 | 1080_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 8.59e-05 | 193 | 212 | 9 | 1284_DN | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; PC3; HT_HG-U133A | ADGRB2 EHBP1L1 PAPOLA KLHL22 SORBS3 NCOA1 FAM53B MYO15A STAG3 | 8.59e-05 | 193 | 212 | 9 | 4225_DN |
| Drug | sulfenosine | 8.63e-05 | 2 | 212 | 2 | CID000129862 | |
| Drug | sulfonosine | 8.63e-05 | 2 | 212 | 2 | CID000129864 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 1670_DN | |
| Drug | Piromidic acid [19562-30-2]; Up 200; 13.8uM; PC3; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 4575_UP | |
| Drug | Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 6070_DN | |
| Drug | Fosfosal [6064-83-1]; Down 200; 18.4uM; PC3; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 4239_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 5457_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 9.29e-05 | 195 | 212 | 9 | 3525_DN | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | EFCAB14 HOXB5 PAPOLA RANBP3 FRMPD1 KLHL22 HIVEP3 PRICKLE3 SORBS3 | 9.29e-05 | 195 | 212 | 9 | 4201_DN |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; HL60; HT_HG-U133A | 9.29e-05 | 195 | 212 | 9 | 2568_DN | |
| Drug | 6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A | 9.29e-05 | 195 | 212 | 9 | 667_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A | 9.29e-05 | 195 | 212 | 9 | 2336_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | RABEP2 DENND2B MAP3K1 ZCCHC14 ZNF329 FRMPD1 RUNX1 KLHL22 FRMD4A | 9.66e-05 | 196 | 212 | 9 | 3314_UP |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | RABEP2 EHBP1L1 AJAP1 DTNA RANBP3 ZDHHC14 HDAC7 CEP164 MANSC1 | 9.66e-05 | 196 | 212 | 9 | 3342_DN |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 3783_DN | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; ssMCF7; HG-U133A | 9.66e-05 | 196 | 212 | 9 | 499_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 4227_DN | |
| Drug | Fosfosal [6064-83-1]; Down 200; 18.4uM; HL60; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 2997_DN | |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; PC3; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 5795_DN | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 4802_DN | |
| Drug | Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; HL60; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 2493_DN | |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | SLC29A3 CUL9 TRIOBP METTL25B PRICKLE3 SORBS3 ORAI3 FAM53B CTNS | 9.66e-05 | 196 | 212 | 9 | 7256_DN |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A | 1.00e-04 | 197 | 212 | 9 | 1909_UP | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 3800_DN | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 4474_DN | |
| Drug | Harpagoside [19210-12-9]; Up 200; 8uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 6636_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | ASH1L KIAA1549L TUT1 HDAC7 METTL25B PRICKLE3 SORBS3 CTNS PCM1 | 1.00e-04 | 197 | 212 | 9 | 6741_DN |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 3255_UP | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 5972_UP | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 4066_DN | |
| Drug | fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A | 1.00e-04 | 197 | 212 | 9 | 281_UP | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; PC3; HT_HG-U133A | HOXB5 PIP4K2A PODXL2 RUNX1 HDAC7 KLHL22 HIVEP3 METTL25B ORAI3 | 1.00e-04 | 197 | 212 | 9 | 5801_DN |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | ZC3H3 FOXO1 EP400 DTNA RANBP3 METTL25B PRICKLE3 SORBS3 STAG3 | 1.00e-04 | 197 | 212 | 9 | 7186_DN |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 1504_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 7472_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 6096_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 4447_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; HL60; HT_HG-U133A | PPM1H PAPOLA PIP4K2A DTNA ZDHHC14 RUNX1 HIVEP3 NCOA1 MPHOSPH9 | 1.04e-04 | 198 | 212 | 9 | 2549_DN |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 4498_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HG-U133A | RABEP2 EFCAB14 HOXB5 MYO19 SIPA1 MANSC1 SORBS3 FAM53B MPHOSPH9 | 1.04e-04 | 198 | 212 | 9 | 1912_DN |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 4970_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; HL60; HG-U133A | 1.04e-04 | 198 | 212 | 9 | 1596_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; HL60; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 2352_DN | |
| Drug | Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 5102_UP | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; HL60; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 2980_UP | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; HL60; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 2990_DN | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 2085_DN | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; HL60; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 3135_UP | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 6328_UP | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 7244_DN | |
| Drug | Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A | ASH1L ADGRB2 DENND2B MAP3K1 HOXB5 EHBP1L1 RANBP3 HDAC7 NCOA1 | 1.08e-04 | 199 | 212 | 9 | 7496_UP |
| Drug | Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 5870_DN | |
| Drug | sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A | 1.08e-04 | 199 | 212 | 9 | 309_DN | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 7398_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 6214_DN | |
| Drug | SC-560; Up 200; 10uM; MCF7; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 6870_UP | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; PC3; HT_HG-U133A | EHBP1L1 GSE1 PIP4K2A FOXO1 RANBP3 ZNF329 METTL25B SORBS3 FAM53B | 1.13e-04 | 200 | 212 | 9 | 5873_DN |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; HL60; HT_HG-U133A | 1.13e-04 | 200 | 212 | 9 | 1869_UP | |
| Drug | vinyl iodide | 1.24e-04 | 11 | 212 | 3 | CID000068976 | |
| Drug | 2,4,4'-trichlorobiphenyl | SOX11 TSHZ2 PROCA1 CD320 EZH2 UBN2 CNTROB DSCAML1 MAP3K1 AJAP1 NAV2 DIP2B FN1 EP400 INTS7 KIF26B DTNA ICE2 MYO19 TRIOBP RFFL RUNX2 VSIG10 CEP164 FRMD4A ASXL3 ANKRD34A FAM53B | 1.27e-04 | 1411 | 212 | 28 | ctd:C081766 |
| Drug | Chloroprene | SOX11 EPRS1 GAPVD1 IL16 TNFSF9 ASH1L IRS1 SIX4 UBN2 F5 NEDD4 NAV2 CX3CL1 FOXO1 FN1 KIF26B DTNA ZNF329 KAT6A ARHGAP9 HIVEP3 RADIL HEATR6 TET1 ANKRD11 SP5 FAM53B | 1.46e-04 | 1348 | 212 | 27 | ctd:D002737 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | SOX11 TSHZ2 PROCA1 CD320 EZH2 UBN2 CNTROB DSCAML1 MAP3K1 AJAP1 NAV2 DIP2B FN1 EP400 INTS7 KIF26B DTNA ICE2 MYO19 TRIOBP RFFL RUNX2 VSIG10 CEP164 FRMD4A ASXL3 ANKRD34A FAM53B | 1.81e-04 | 1441 | 212 | 28 | ctd:C009828 |
| Drug | geldanamycin | EPRS1 UBN2 MAP3K1 SLAIN2 FN1 HCN1 ICE2 KAT6A RESF1 LMO7 PCM1 TP53BP1 | 1.99e-04 | 371 | 212 | 12 | ctd:C001277 |
| Drug | ZnBr2 | 2.57e-04 | 3 | 212 | 2 | CID000024375 | |
| Drug | acetoacetic ester | 2.69e-04 | 14 | 212 | 3 | CID000008868 | |
| Drug | Methamphetamine | RALGAPA1 SLC29A3 ATXN7L1 SPEG CUL9 SIX4 EHBP1L1 AJAP1 FN1 EP400 CD177 PPM1D SYNE1 RANBP3 AOAH KAT6A LAMB2 ARHGAP9 TUT1 HDAC7 KLHL22 PRICKLE3 LMO7 ANKRD11 MACF1 RIMS2 PCNT | 2.71e-04 | 1401 | 212 | 27 | ctd:D008694 |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | 3.05e-04 | 181 | 212 | 8 | 3106_DN | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 3.17e-04 | 182 | 212 | 8 | 7067_DN | |
| Drug | AC1L8ZA3 | 3.33e-04 | 15 | 212 | 3 | CID000410507 | |
| Drug | AC1OAGFW | 3.41e-04 | 184 | 212 | 8 | CID006857352 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A | 3.54e-04 | 185 | 212 | 8 | 2927_DN | |
| Disease | Malignant neoplasm of breast | SIX4 EZH2 MAP3K1 NEDD4 ZCCHC14 OSBPL11 ZNF438 FN1 PPM1D SYNE1 ROR1 FRMPD1 HDAC7 SBNO1 PRICKLE3 ANKRD34A NCOA1 MACF1 USP54 REPS2 SPEN TP53BP1 | 6.40e-06 | 1074 | 205 | 22 | C0006142 |
| Disease | urate measurement, bone density | UBE4B TSHZ2 TNFSF9 CLASP2 GRAMD1B SALL1 GSE1 SYNE1 AOAH ZDHHC14 GRID1 RUNX1 HEATR6 MANSC1 PLXNA4 ANKRD11 | 7.65e-06 | 619 | 205 | 16 | EFO_0003923, EFO_0004531 |
| Disease | obsolete_red blood cell distribution width | ASXL1 EZH2 DENND2B PPM1H MAP3K1 GFI1B PLEKHG1 EHBP1L1 NFE2L1 HERC1 GNL3 DIP2B EP400 PCDHGA5 MYO19 AOAH ZDHHC14 RUNX1 SIPA1 ZFPM2 FRMD4A METTL25B RESF1 GAREM2 CHSY3 | 8.02e-06 | 1347 | 205 | 25 | EFO_0005192 |
| Disease | cup-to-disc ratio measurement | SERPINE3 F5 EHBP1L1 SALL1 KIAA1549L NAV2 TRIOBP ARHGAP9 MAPRE1 FRMD4A INTS6 TET1 CHSY3 | 1.10e-05 | 430 | 205 | 13 | EFO_0006939 |
| Disease | Dysosteosclerosis | 4.80e-05 | 2 | 205 | 2 | C0432262 | |
| Disease | 46,XY partial gonadal dysgenesis | 5.23e-05 | 11 | 205 | 3 | C4510744 | |
| Disease | venous thromboembolism | LEMD3 ATXN7L1 ZC3H3 F5 NAV2 PSG8 KIF26B ZFPM2 SBNO1 PLXNA4 MPHOSPH9 CCDC181 | 9.87e-05 | 460 | 205 | 12 | EFO_0004286 |
| Disease | mean platelet volume | PROCA1 IRS1 DENND2B GRAMD1B GFI1B DCANP1 GSE1 NFE2L1 WIPF1 PCDHGA5 PCDHGA2 ZDHHC14 RUNX1 HDAC7 ZFPM2 MAPRE1 PRICKLE3 ANKRD11 FAM53B | 9.96e-05 | 1020 | 205 | 19 | EFO_0004584 |
| Disease | Prostatic Neoplasms | IL16 ASH1L IRS1 EZH2 MAP3K1 CX3CL1 FOXO1 KAT6A LAMB2 RUNX1 SP5 NCOA1 NCOA7 SPEN | 1.13e-04 | 616 | 205 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | IL16 ASH1L IRS1 EZH2 MAP3K1 CX3CL1 FOXO1 KAT6A LAMB2 RUNX1 SP5 NCOA1 NCOA7 SPEN | 1.13e-04 | 616 | 205 | 14 | C0376358 |
| Disease | Colorectal Carcinoma | F5 DSCAML1 GFI1B GSE1 PAX8 NPAP1 ETAA1 TBX22 FN1 SYNE1 ARFGEF1 GRID1 HIVEP3 LMO7 PRKD1 | 1.27e-04 | 702 | 205 | 15 | C0009402 |
| Disease | brain measurement, neuroimaging measurement | DSCAML1 MAP3K1 NAV2 ZNF438 DIP2B KIF26B ROR1 TRIOBP BEND3 RUNX2 SBNO1 MACF1 FAM53B | 1.36e-04 | 550 | 205 | 13 | EFO_0004346, EFO_0004464 |
| Disease | eosinophil percentage of leukocytes | ATXN7L1 INPP5D GFI1B SALL1 GSE1 CX3CL1 FOXO1 KIF27 ICE2 BEND3 RUNX2 RUNX1 HIVEP3 RESF1 FAM53B | 2.45e-04 | 746 | 205 | 15 | EFO_0007991 |
| Disease | eosinophil count | ATXN7L1 INPP5D NACAD GFI1B PHC3 SALL1 GSE1 CX3CL1 FOXO1 DIP2B KIF27 CD177 ICE2 BEND3 RUNX2 RUNX1 IHO1 HIVEP3 RESF1 ATF7IP ANKRD11 MPHOSPH9 TP53BP1 | 2.91e-04 | 1488 | 205 | 23 | EFO_0004842 |
| Disease | Juvenile Myelomonocytic Leukemia | 2.95e-04 | 19 | 205 | 3 | C0349639 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 4.34e-04 | 194 | 205 | 7 | EFO_0004265, EFO_0007908 | |
| Disease | cadherin-7 measurement | 4.74e-04 | 5 | 205 | 2 | EFO_0801438 | |
| Disease | chronic myelomonocytic leukemia (is_implicated_in) | 4.74e-04 | 5 | 205 | 2 | DOID:0080188 (is_implicated_in) | |
| Disease | cerebellar ataxia (is_implicated_in) | 4.74e-04 | 5 | 205 | 2 | DOID:0050753 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 4.88e-04 | 93 | 205 | 5 | C1535926 | |
| Disease | brain connectivity measurement | SOX11 NEDD4 PLEKHG1 DMRT3 PAX8 NAV2 MTUS2 KIF26B TRIOBP FAM53B | 5.22e-04 | 400 | 205 | 10 | EFO_0005210 |
| Disease | hemorrhoid | 5.86e-04 | 147 | 205 | 6 | EFO_0009552 | |
| Disease | osteonecrosis | 6.79e-04 | 25 | 205 | 3 | EFO_0004259 | |
| Disease | mental development measurement | 6.79e-04 | 25 | 205 | 3 | EFO_0008230 | |
| Disease | glucagon measurement, glucose tolerance test | 7.07e-04 | 6 | 205 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | blood cobalt measurement | 7.11e-04 | 101 | 205 | 5 | EFO_0007577 | |
| Disease | Alzheimer disease, polygenic risk score | INPP5D MAP3K20 NFE2L1 PIP4K2A PCDHGA5 HCN1 PCDHGA2 RUNX2 RESF1 SBNO1 CHSY3 STAG3 | 8.72e-04 | 586 | 205 | 12 | EFO_0030082, MONDO_0004975 |
| Disease | FEV/FEC ratio | ASXL1 SPEG MAP3K20 DENND2B MAP3K1 NAV2 HERC1 ZNF438 FOXO1 C1orf54 PCDHGA5 HCN1 TUT1 RUNX2 HIVEP3 MAPRE1 FRMD4A ANKRD11 MYO15A | 9.84e-04 | 1228 | 205 | 19 | EFO_0004713 |
| Disease | peripheral vascular disease | 9.86e-04 | 7 | 205 | 2 | EFO_0003875 | |
| Disease | Epilepsy | 1.00e-03 | 109 | 205 | 5 | C0014544 | |
| Disease | Hematopoetic Myelodysplasia | 1.06e-03 | 29 | 205 | 3 | C2713368 | |
| Disease | myelodysplastic syndrome (is_implicated_in) | 1.17e-03 | 30 | 205 | 3 | DOID:0050908 (is_implicated_in) | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.23e-03 | 67 | 205 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | Male sterility due to Y-chromosome deletions | 1.31e-03 | 8 | 205 | 2 | C2931163 | |
| Disease | Gonadal Dysgenesis, 46,XY | 1.31e-03 | 8 | 205 | 2 | C0018054 | |
| Disease | Partial chromosome Y deletion | 1.31e-03 | 8 | 205 | 2 | C1507149 | |
| Disease | myelofibrosis (is_implicated_in) | 1.31e-03 | 8 | 205 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | phenol sulfate measurement | 1.31e-03 | 8 | 205 | 2 | EFO_0021011 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.67e-03 | 9 | 205 | 2 | C3502809 | |
| Disease | pentachlorophenol measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 1.69e-03 | 73 | 205 | 4 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 1.78e-03 | 74 | 205 | 4 | EFO_0007886 | |
| Disease | dental caries | 2.02e-03 | 187 | 205 | 6 | EFO_0003819 | |
| Disease | cup-to-disc ratio measurement, optic cup area measurement, optic disc area measurement | 2.08e-03 | 10 | 205 | 2 | EFO_0006937, EFO_0006939, EFO_0006940 | |
| Disease | renal Wilms' tumor (is_implicated_in) | 2.08e-03 | 10 | 205 | 2 | DOID:5176 (is_implicated_in) | |
| Disease | chronic fatigue syndrome (is_marker_for) | 2.08e-03 | 10 | 205 | 2 | DOID:8544 (is_marker_for) | |
| Disease | nose morphology measurement | 2.22e-03 | 329 | 205 | 8 | EFO_0007843 | |
| Disease | Glioblastoma | 2.26e-03 | 79 | 205 | 4 | C0017636 | |
| Disease | memory performance | 2.36e-03 | 409 | 205 | 9 | EFO_0004874 | |
| Disease | platelet component distribution width | GAPVD1 IRS1 ZNF490 GFI1B GSE1 NFE2L1 HERC1 WIPF1 SYNE1 ZDHHC14 HDAC7 ZFPM2 MACF1 | 2.52e-03 | 755 | 205 | 13 | EFO_0007984 |
| Disease | brain-derived neurotrophic factor measurement | 2.54e-03 | 11 | 205 | 2 | EFO_0011018 | |
| Disease | Epilepsy, Cryptogenic | 2.59e-03 | 82 | 205 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 2.59e-03 | 82 | 205 | 4 | C0751111 | |
| Disease | Aura | 2.59e-03 | 82 | 205 | 4 | C0236018 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.83e-03 | 84 | 205 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.03e-03 | 12 | 205 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | C-C motif chemokine 17 measurement | 3.03e-03 | 12 | 205 | 2 | EFO_0008045 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.03e-03 | 12 | 205 | 2 | C0023485 | |
| Disease | disks large homolog 3 measurement | 3.03e-03 | 12 | 205 | 2 | EFO_0802472 | |
| Disease | tumor necrosis factor receptor superfamily member EDAR measurement | 3.03e-03 | 12 | 205 | 2 | EFO_0008310 | |
| Disease | X-12707 measurement | 3.03e-03 | 12 | 205 | 2 | EFO_0800720 | |
| Disease | total hip arthroplasty, osteoarthritis | 3.11e-03 | 42 | 205 | 3 | EFO_0009806, MONDO_0005178 | |
| Disease | intraocular pressure measurement | SOX11 ADGRB2 NEDD4 FOXO1 PCDHGA5 TRIOBP RUNX2 HIVEP3 THBS4 LMO7 | 3.12e-03 | 509 | 205 | 10 | EFO_0004695 |
| Disease | childhood gender nonconformity | 3.32e-03 | 43 | 205 | 3 | EFO_0020103 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 3.35e-03 | 88 | 205 | 4 | EFO_0803332 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.78e-03 | 45 | 205 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | EZH2 MAP3K1 FN1 PPM1D SYNE1 ROR1 ANKRD34A NCOA1 REPS2 TP53BP1 | 3.88e-03 | 525 | 205 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | EZH2 MAP3K1 FN1 PPM1D SYNE1 ROR1 ANKRD34A NCOA1 REPS2 TP53BP1 | 3.88e-03 | 525 | 205 | 10 | C1257931 |
| Disease | Mammary Neoplasms | EZH2 MAP3K1 FN1 PPM1D SYNE1 ROR1 ANKRD34A NCOA1 REPS2 TP53BP1 | 3.98e-03 | 527 | 205 | 10 | C1458155 |
| Disease | neuroimaging measurement, brain volume measurement | 4.00e-03 | 286 | 205 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 4.03e-03 | 46 | 205 | 3 | EFO_0008003, GO_0097332 | |
| Disease | colonic neoplasm, overall survival | 4.14e-03 | 14 | 205 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 4.14e-03 | 14 | 205 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | thalamus volume change measurement | 4.14e-03 | 14 | 205 | 2 | EFO_0021496 | |
| Disease | Salivary Gland Neoplasms | 4.28e-03 | 47 | 205 | 3 | C0036095 | |
| Disease | Breast Carcinoma | EZH2 MAP3K1 FN1 PPM1D SYNE1 ROR1 ANKRD34A NCOA1 REPS2 TP53BP1 | 4.59e-03 | 538 | 205 | 10 | C0678222 |
| Disease | Tinnitus, response to cisplatin | 4.75e-03 | 15 | 205 | 2 | GO_0072718, HP_0000360 | |
| Disease | acute myeloid leukemia (is_marker_for) | 4.81e-03 | 49 | 205 | 3 | DOID:9119 (is_marker_for) | |
| Disease | hematocrit | RALGAPA1 ASH1L DENND2B PLEKHG1 SALL1 NFE2L1 FOXO1 SLAIN2 RUNX1 CEP164 ZFPM2 FRMD4A ORAI3 NCOA7 TP53BP1 | 4.89e-03 | 1011 | 205 | 15 | EFO_0004348 |
| Disease | monocyte count | RALGAPA1 ASXL1 INPP5D ASH1L KLHDC7B DENND2B GFI1B GSE1 NPAT FOXO1 FN1 BEND3 ARHGAP9 RUNX2 RUNX1 ZFPM2 HIVEP3 NCOA1 | 5.10e-03 | 1320 | 205 | 18 | EFO_0005091 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVPSPLLSSASARNA | 1136 | O60241 | |
| ASVSPTRNSSNTLPI | 171 | Q9UMD9 | |
| SSPVNRPSSATNKAL | 721 | Q96L91 | |
| DSQSRRVSSSQQPPL | 216 | Q8TF63 | |
| SQLAPNPLLLSSTTE | 576 | Q9NR48 | |
| SLSANNTPTRRVSPL | 576 | Q9UJX2 | |
| NTPTRRVSPLNLSSV | 581 | Q9UJX2 | |
| LSENASQAPARPLST | 1771 | Q6UB99 | |
| APSASSDISASRPNI | 26 | P51690 | |
| PSLPDDRLSVSSNDT | 386 | Q9Y6D6 | |
| AVADSLTNSPRDSPA | 901 | Q14687 | |
| LTNSPRDSPAVSLSE | 906 | Q14687 | |
| NLTDFPSARVPSSLD | 331 | Q9UKB5 | |
| SLPSRLDSVPRNTDS | 891 | Q9P2G1 | |
| SASSSSVLLNSLPPQ | 301 | Q8N6Q3 | |
| SRNTSTIDPTQPQLL | 1771 | Q96M86 | |
| LAQLSLPSSPSSLNE | 581 | P78524 | |
| PSTSEQNLASAAPRQ | 71 | Q8TF44 | |
| ARSQLFPPTEAQSTA | 96 | Q8IWY9 | |
| LDPTNAENTASQSPR | 166 | Q9UER7 | |
| SNQIIPSPSATSELD | 241 | O75071 | |
| AEASARQPQTLASSP | 356 | Q6HA08 | |
| SNSNRSTPACSPILR | 11 | Q3KR37 | |
| NSVLPRPSSANSISS | 396 | Q9ULK2 | |
| CSTESQSRPLSNPRD | 136 | Q8IXJ9 | |
| SNLPLTSEASPVSNL | 696 | Q9C0F0 | |
| RQSQESLPGAVSPLS | 381 | Q69YU3 | |
| STSARADSVLNIPAP | 521 | Q5JR59 | |
| STLLPLAPSNSTSLN | 391 | Q14494 | |
| RERTSSLTQFPPSQS | 121 | Q9H6Z4 | |
| ATLTPSNTPLGRNLS | 276 | Q06710 | |
| DSGNPPLSSNVSLSL | 536 | Q9Y5H1 | |
| SSSLPQSRQGLSPEQ | 246 | Q9H5N1 | |
| FSASSPASLLERPTN | 736 | Q9UL03 | |
| IASLTAASTPLNPLS | 601 | Q9NVH2 | |
| DSGNPPLSSNVSLSL | 536 | Q9Y5G8 | |
| TPSESPRAQATSRLS | 266 | Q9NQX3 | |
| SLRLLNPSRPQSTES | 236 | P0C860 | |
| TLAPVATSLSPASNL | 196 | Q9BRQ5 | |
| NNSTALQLASRPPDS | 671 | Q96NI6 | |
| PPSAAVAASSSLRIN | 411 | Q9Y2U8 | |
| NSRPSSKNLTNSSIP | 1381 | Q14207 | |
| SETSLSPVNALPAAA | 216 | Q96JH8 | |
| ASNSPSSLRLLNEPQ | 161 | Q5T5X7 | |
| SSASPANDDQSRPSL | 21 | P28039 | |
| PQVRDFSLTSSSQTP | 201 | Q9NZ53 | |
| PDIFSVASSRLSNSP | 4656 | Q8WXI7 | |
| DANRTISPSTSNNIP | 391 | Q15139 | |
| DLASLSPVASTDSQP | 226 | P13349 | |
| SSLRAENQSTTLPGP | 331 | Q7Z353 | |
| PLPTISSSAENTRQN | 161 | P42166 | |
| LPSDSTSNRSVPNRN | 206 | P46934 | |
| DSTQLRPPQSALSTT | 531 | Q9HCH0 | |
| RNAPSPAATSSIAIS | 436 | Q9H9P8 | |
| FSSVPASRPSEQLLQ | 3326 | Q9UKN7 | |
| SQAPCSLSTSPLQTR | 841 | Q96H55 | |
| SQTSPPLAQSLNLTR | 271 | Q8IYA8 | |
| NSSSIRRTAPTAALP | 386 | Q8WXT5 | |
| RDQAPSNSPVLSTLF | 36 | Q5VTD9 | |
| LEAAASPLSTPTSAQ | 31 | Q9NPF0 | |
| PLVQSPSLQSSRESL | 1036 | Q2KJY2 | |
| PENPLLQTSCINSST | 616 | Q8WW38 | |
| FSTLTDDPSPRLSAQ | 1011 | Q14C86 | |
| LTSPDSQSARPANRT | 2721 | Q15751 | |
| PANRTALSDPSSRLS | 2731 | Q15751 | |
| ANSTPASTPELARRS | 246 | Q14153 | |
| NSSRPSTPTINVLES | 361 | Q15910 | |
| SSASSLRTQPNPQKL | 1281 | Q86VH2 | |
| SPQRSVDQRSTSAPS | 431 | Q15154 | |
| GSSTLLTRQPAPLSQ | 21 | Q9HCM2 | |
| VNSSASLSPDRLNSP | 6 | P35408 | |
| ASAVESLRPSQQAPS | 501 | Q92817 | |
| SRPTRSLSTAQLVQP | 191 | Q14005 | |
| SNSVLQSRNAPLPSL | 821 | Q9ULH7 | |
| SANEIPPLQSSSEDR | 981 | Q9ULH7 | |
| ELRNQTPAPSAAQTS | 66 | Q9P265 | |
| QAPPALVSSSQSLLE | 1031 | Q8N3D4 | |
| PQQSESSASRPTLNK | 301 | Q6AI08 | |
| RLNSASQRSSSLPPS | 796 | Q99550 | |
| TLAEQSLNIASPPSL | 2586 | O94854 | |
| QSPVEEQSPASLSSL | 866 | Q8WWI1 | |
| TDFPSLTRNLPSQEL | 121 | Q9H8J5 | |
| RANTSALAVPSPVSN | 1346 | P55268 | |
| DSPLSAASSSRNLEP | 76 | O95568 | |
| SDINSSPERNASTPF | 576 | Q6ZVL6 | |
| PLPTISSSAENTRQN | 161 | P42167 | |
| EFLENPSQSSRLTAP | 111 | Q96FB5 | |
| AQPASLPTTSQRKNS | 561 | O15297 | |
| QSSSNCSNPISVPLR | 271 | P35568 | |
| ATPSPNSRLERSLTA | 3281 | O95613 | |
| TSPTPAQLISRSQAS | 131 | Q8NDX5 | |
| PLLLPAATTRSNSTS | 666 | Q8NDX5 | |
| SLTQQESLSRTIPPD | 381 | Q9UHF4 | |
| SSPLTRTSSDPNLNN | 621 | Q9NYA4 | |
| SNKTPRSLSSQVDTP | 336 | Q9NY74 | |
| ASQLSSPSLARAQPE | 146 | P09067 | |
| RNSPAPAVTAASVTN | 556 | P51003 | |
| TSSTDLSDIPALPAN | 716 | P51003 | |
| NDSLSSDQSESVRPP | 511 | Q9UQ26 | |
| ETFNSPSLSLPRDSR | 586 | O43900 | |
| SQSVRSVSSPNVPAL | 1491 | Q92794 | |
| DPQQLLPRSSNSSVS | 251 | Q5TID7 | |
| ALPQSQRSSTPSSEI | 986 | Q9P2Q2 | |
| ALPRESSSVLNTDPD | 866 | O60741 | |
| ASTLPSLSEISNPEN | 356 | Q12778 | |
| TVAPSAPDISANSRS | 441 | Q659A1 | |
| SLQPSLQSPQTELRS | 281 | Q53GT1 | |
| QSAANPETPNSTISR | 166 | Q9NQZ3 | |
| QSAANPETPNSTISR | 331 | Q9NQZ3 | |
| AASPELSSPLANQSL | 271 | Q7RTS9 | |
| ERTSAEPESLALPSN | 296 | Q9NQL9 | |
| LARSQSSPFLPNDVT | 376 | Q9NQL9 | |
| PAAASTATLPQRTLA | 1961 | Q8TD84 | |
| APSNLRFLATTPNSL | 1996 | P02751 | |
| SSGPDTAQARPSQIL | 976 | Q5SYB0 | |
| SLAAPISPSRAASQT | 296 | P0CW27 | |
| QRNPTASAAPLGTTL | 856 | Q6VMQ6 | |
| SSAAPQRPISTQRTA | 156 | Q15691 | |
| TSLQRSQSNPILGSP | 586 | Q9NYL2 | |
| RPSSDLNNSTLQSPA | 391 | Q9P0L2 | |
| QSLPASPRARLSAST | 441 | Q3KQU3 | |
| AARLAAESSSSQPPQ | 441 | Q9Y4J8 | |
| VSPLNSSSALALRSP | 311 | Q9BVP2 | |
| AQSAAQPRPSASATL | 591 | Q9ULK0 | |
| AASSSARRSQPVPQL | 116 | Q96G42 | |
| SPVLPSSSLRNITQC | 1461 | Q8IWT3 | |
| NPRPLSFQSELTASA | 86 | Q6UXQ4 | |
| LELLTSSNPPASASQ | 11 | Q9H2J1 | |
| NGSSTNVSLTLRPPL | 36 | O60931 | |
| QSAANPETPNSTISR | 166 | Q86SG3 | |
| APEPASQARVLSSSE | 496 | Q8WUI4 | |
| QTPSRPSQLDVSLSA | 1006 | Q9Y2H2 | |
| LLASQNADLPTSSSP | 256 | Q9NSC2 | |
| LGIDLTAPSNNSSPR | 681 | A3KN83 | |
| SPPDVSRSLSARQLA | 276 | Q8NCQ7 | |
| QEARSSQAPSSRPIS | 51 | Q8N4L8 | |
| NTRPLQDLSPSSSAQ | 146 | Q8N137 | |
| LTRSAPLPNDSQARS | 116 | P48426 | |
| ELTLSSVNSPIPENS | 346 | Q9Y5E6 | |
| ASSSNSPISQRRPSQ | 176 | Q9BXB4 | |
| SLAETATSPDNPRRS | 351 | P78415 | |
| SSPVDSPSSLRAAQQ | 506 | Q13233 | |
| STTQPSQASRALTEP | 576 | Q75VX8 | |
| TNASTGSALLNPSLP | 406 | Q01196 | |
| SDPRQFPSISSLTES | 371 | Q13950 | |
| LPQDSLSAPSVASRF | 276 | Q9BZD2 | |
| LAQPALSPASSRSVS | 326 | P35716 | |
| QPPLSQSSDSSPTRN | 876 | P07814 | |
| SLQAFLQDRTPSASP | 11 | Q6BEB4 | |
| SANPPSNINSATLTR | 511 | Q9P270 | |
| DSLLSPQPSSNLSLS | 8246 | Q8NF91 | |
| PNNPSDLTVTSRGLT | 881 | Q14DG7 | |
| RPEPTNSSLNLSVTS | 46 | P12259 | |
| TNLSPELSQTNLSPA | 1256 | P12259 | |
| FVPDANSPSSTLRLS | 156 | Q8NI08 | |
| TRASTLSPDFPEQQA | 146 | Q8WZ73 | |
| NSVLTLPSRQTSAVP | 251 | Q9HCM1 | |
| PASLQSATARPTSRL | 851 | Q15788 | |
| NPVSASRSDPFTLNL | 221 | Q9UQ74 | |
| NSSSIRRTAPTAALP | 386 | Q5VV16 | |
| SRAPSQVSISASPRQ | 1966 | Q8IVL1 | |
| LATTANQRFSSPAPS | 681 | Q96QT6 | |
| TPNQSPLSIRGSLFS | 531 | Q15858 | |
| SNENPRATETSRPSL | 146 | Q92835 | |
| SLSPSTLLNPTELNR | 621 | Q9UIU6 | |
| NSLSPRSSLSDEAPV | 836 | Q96FS4 | |
| ADRLPTQAPLSTSQS | 1141 | Q6ZUB1 | |
| TSLPAQSVRAPATAS | 746 | Q9NZP6 | |
| ASSPNRTTQQDSPRT | 636 | Q9H2D6 | |
| LEASPAARSLQTPSA | 106 | Q9H6W3 | |
| PQQASPSRDSSTDLT | 366 | P11831 | |
| PPANLTAARVTATSA | 1106 | Q8TER0 | |
| ALTQLSEAPSENSSP | 896 | Q8NFU7 | |
| SPDLNDAVSSLRSPI | 101 | Q8WWF1 | |
| SSVLSILDSLNPQSP | 1276 | Q9UPV0 | |
| SAAENQPPRQSLSSI | 476 | Q70JA7 | |
| SSRDTSPVRSFQPLA | 536 | O75122 | |
| STQQLTLSPAAVPTR | 876 | Q9NRU3 | |
| TSLSASPVSNLSNPR | 771 | Q01973 | |
| ATPQVFDLLPSSSQR | 26 | P35443 | |
| TTPPQDSSQRLTHDA | 521 | O94967 | |
| SQRPTRQTPSSAALT | 836 | Q8IXZ2 | |
| RQSPTLNLLPSSRTS | 1121 | Q6ZU65 | |
| STSQIPDLNTNLETP | 136 | Q9ULM2 | |
| LNEEQPLPRSSSTSD | 786 | Q6GYQ0 | |
| QSAAVPAPTSQLLSS | 311 | Q96T58 | |
| LPQLSRAPSQAAESS | 536 | Q8NFH8 | |
| LQESPSLSALSEAQP | 2161 | Q15772 | |
| SLSALSEAQPSSPAR | 2166 | Q15772 | |
| SSQEESLQLNSIPPT | 1091 | Q9UJ98 | |
| PENTPANSRTLTRAA | 196 | Q9ULR3 | |
| LVLPAPERLASSNSS | 386 | Q9Y458 | |
| PERLASSNSSQSLAP | 391 | Q9Y458 | |
| APQTPDSALASETLA | 286 | Q9H6E5 | |
| TTQDSQPSPLALLAA | 26 | Q02086 | |
| TATSQPIAAAARSPD | 226 | O95155 | |
| PSLASPSRAASQLAV | 291 | O95155 | |
| LASSPQAVPASSSRQ | 356 | O95155 | |
| TTVLRPTSQLPNAAT | 246 | Q9H0E3 | |
| TPPSDVSTRNLLSDS | 171 | A1A519 | |
| VPLSRSPSQESNVSL | 926 | Q5T1R4 | |
| SPVRSRSLSFSEPQQ | 441 | Q9H8N7 | |
| PADLSEPNSTAIQTS | 141 | A8MV23 | |
| TPRLPQRNLSLSSST | 331 | O43516 | |
| QLPTSPRLTAAARSA | 526 | O60504 | |
| PLDPQGSLSLSQRTS | 286 | Q9BRR9 | |
| GSLSLSQRTSQLDPP | 291 | Q9BRR9 | |
| ILPRPSSLSASNSTQ | 636 | Q68DE3 | |
| QAVPSPATRSEALSS | 626 | Q12888 | |
| SSPATSRNLVLTPVN | 281 | Q86VD9 | |
| AELQPSRPTSLSQDS | 476 | O43548 | |
| SNPVDLSNPAIISST | 291 | Q86X10 | |
| SLQQNLPSRSVSKPS | 176 | Q9NRE2 | |
| LTVDLPPASSEARNS | 181 | P41273 | |
| QAAATPLLQSEPSLT | 371 | Q8IZN3 | |
| DFPLRLVSAAPSQTS | 91 | A0A0A6YYG3 | |
| RRFLSTSSPPQQLQS | 196 | Q8WYQ9 | |
| SEPVFLLSSNSSLRP | 61 | Q8N0Z9 | |
| SPQESSLLRSVSPSQ | 1061 | Q9ULL1 | |
| AQQELPSSSRDPSTL | 451 | Q6UX68 | |
| PSRSDQVNLGPSINS | 56 | Q7Z4V0 | |
| SSDLPPSQRVLATNG | 76 | Q86UD4 | |
| EAARAQPTPSSSATQ | 11 | P61964 | |
| SSIPQDAATVPSLAA | 76 | Q8N228 | |
| LESPSRSSSPANQRA | 116 | Q9ULM3 | |
| SVNSSSLVSPPQRIS | 46 | P51522 | |
| SSLEPTPSSQEAQRA | 136 | P78423 | |
| ERNSSSPVSLDAALP | 666 | Q70EL1 | |
| SSQALSTEAPLPATL | 101 | O15069 |